Showing results (911-920 of 1,551) with videos related to

Sort By:
Pageof 156
Contemporary Clinical Trials Communications|April 27, 2018
The administration of patient-reported outcome questionnaires in cancer trials: Interviews with trial coordinators regarding their roles, experiences, challenges and trainingRebecca Mercieca-Bebber, Melanie Calvert, Derek Kyte, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Barriers to non-small cell lung cancer trial eligibilityJeffrey J Hardesty, Norma F Kanarek
Contemporary Clinical Trials Communications|April 27, 2018
Where are they now? Retention strategies over 25 years in the Coronary Artery Risk Development in Young Adults (CARDIA) StudyEllen Funkhouser, Jennifer Wammack, Cathy Roche, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Interval estimation of the overall treatment effect in a meta-analysis of a few small studies with zero eventsKonstantinos Pateras, Stavros Nikolakopoulos, Dimitris Mavridis, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Quantifying and visualizing site performance in clinical trialsEric Yang, Christopher O'Donovan, JodiLyn Phillips, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Temporal trends and characteristics of clinical trials for which only one racial or ethnic group is eligibleBrian L Egleston, Omar Pedraza, Yu-Ning Wong, et al.
Contemporary Clinical Trials Communications|May 10, 2018
Comparative effectiveness of pediatric integrative medicine as an adjunct to usual care for pediatric inpatients of a North American tertiary care centre: A study protocol for a pragmatic cluster controlled trialSunita Vohra, Michael Schlegelmilch, Hsing Jou, et al.
Contemporary Clinical Trials Communications|May 10, 2018
Strategies to exclude subjects who conceal and fabricate information when enrolling in clinical trialsEric G Devine, Kristina R Peebles, Valeria Martini
Contemporary Clinical Trials Communications|May 10, 2018
Innovative methods for the identification of predictive biomarker signatures in oncology: Application to bevacizumabPaul Delmar, Cornelia Irl, Lu Tian
Contemporary Clinical Trials Communications|May 10, 2018
The distribution of the modified Rankin scale scores change according to eligibility criteria in acute ischemic stroke trials: A consideration for sample size calculations when using ordinal regression analysisVerónica V Olavarría, Alejandro Brunser, Norberto Cabral, et al.
Pageof 156